Comparing WuXi PharmaTech (Cayman) (WX) & Its Competitors

WuXi PharmaTech (Cayman) (NYSE: WX) is one of 187 publicly-traded companies in the “Biotechnology & Medical Research” industry, but how does it compare to its peers? We will compare WuXi PharmaTech (Cayman) to similar companies based on the strength of its analyst recommendations, institutional ownership, profitability, risk, valuation, dividends and earnings.

Valuation & Earnings

This table compares WuXi PharmaTech (Cayman) and its peers top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
WuXi PharmaTech (Cayman) N/A N/A 38.91
WuXi PharmaTech (Cayman) Competitors $207.03 million -$40.51 million -65.10

WuXi PharmaTech (Cayman)’s peers have higher revenue, but lower earnings than WuXi PharmaTech (Cayman). WuXi PharmaTech (Cayman) is trading at a higher price-to-earnings ratio than its peers, indicating that it is currently more expensive than other companies in its industry.

Institutional and Insider Ownership

49.1% of shares of all “Biotechnology & Medical Research” companies are held by institutional investors. 14.9% of shares of all “Biotechnology & Medical Research” companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent recommendations and price targets for WuXi PharmaTech (Cayman) and its peers, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
WuXi PharmaTech (Cayman) 0 0 0 0 N/A
WuXi PharmaTech (Cayman) Competitors 660 2474 6677 136 2.63

As a group, “Biotechnology & Medical Research” companies have a potential upside of 11.73%. Given WuXi PharmaTech (Cayman)’s peers higher probable upside, analysts clearly believe WuXi PharmaTech (Cayman) has less favorable growth aspects than its peers.

Profitability

This table compares WuXi PharmaTech (Cayman) and its peers’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
WuXi PharmaTech (Cayman) 7.52% 6.93% 4.67%
WuXi PharmaTech (Cayman) Competitors -4,498.55% -497.76% -42.78%

WuXi PharmaTech (Cayman) Company Profile

WuXi PharmaTech (Cayman) Inc. is a pharmaceutical, biotechnology and medical device research and development (R&D) services company, with operations in China and the United States. The Company provides a portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process to its customers. It conducts its operations in two segments: Laboratory services and Manufacturing services. The Company offers Laboratory services for pharmaceutical, biotechnology and medical device companies. It offers Manufacturing services, which include the development of manufacturing processes and the production of advanced intermediates and active pharmaceutical ingredients (APIs) for use by pharmaceutical companies in preclinical and clinical trials of small-molecule products and in commercial products, as well as the production of biologic products.

Receive News & Ratings for WuXi PharmaTech (Cayman) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi PharmaTech (Cayman) and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply